NCT04165850
- Conditions
- ALS, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
- Locations
-
- Sourasky Medical Center Tel Aviv, Israel
Clinical trial condition
Amyotrophic Lateral Sclerosis
Explore clinical trials studying Amyotrophic Lateral Sclerosis. Study availability and eligibility vary by location and protocol.
707 public trials
173 recruiting studies
Amyotrophic Lateral Sclerosis trial results
NCT03168711
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Holy Cross Hospital Fort Lauderdale, Florida, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- University of Minnesota Minneapolis, Minnesota, United States
Completed
Predict to Prevent Frontotemporal Lobar Degeneration (FDT) and Amyotrophic Lateral Sclerosis (ALS)
NCT02590276
- Conditions
- Amyotrophic Lateral Sclerosis, Brain Diseases, Central Nervous System Diseases, +14 more
- Locations
-
- Groupe Hospitalier Pitié-Salpêtrière - Charles Foix Paris, France
NCT03482050
- Conditions
- ALS (Amyotrophic Lateral Sclerosis), Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +9 more
- Locations
-
- Hadassah Ein Kerem Medical Center Jerusalem, Israel
Completed
MRI Biomarkers in ALS
NCT02405182
- Conditions
- ALS, Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, +10 more
- Locations
-
- University of Calgary / Heritage Medical Research Clinic Calgary, Alberta, Canada
- University of Alberta Edmonton, Alberta, Canada
- University of British Columbia / GF Strong Rehab Centre Vancouver, British Columbia, Canada
- Western University / London Health Sciences Centre London, Ontario, Canada
NCT00790582
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Mayo Clinic Scottsdale, Arizona, United States
- UCLA Neuromuscular Research Center Los Angeles, California, United States
- UC Irvine MDA/ALS & Neuromuscular Center Orange, California, United States
- California Pacific Medical Center San Francisco, California, United States
Completed
Safety and Biomarker Study of EPI-589 in Participants With Amyotrophic Lateral Sclerosis (ALS)
NCT02460679
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Cedar's Sinai Los Angeles, California, United States
- California Pacific Medical Center San Francisco, California, United States
- Providence Brain and Spine Institute ALS Center Portland, Oregon, United States
NCT02414230
- Conditions
- Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Central Nervous System Diseases, +10 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
NCT04446325
- Conditions
- Amyotrophic Lateral Sclerosis, Cardiovascular Diseases, Central Nervous System Diseases, +19 more
- Locations
-
- CHRU de Brest Brest, France
NCT03160898
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- St. Joseph's Hospital and Medical Center - Barrow Neurological Clinics Phoenix, Arizona, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- University of California Irvine Orange, California, United States
- Forbes Norris MDA/ALS Research Center San Francisco, California, United States